Company / PP&E (Net)
Co-Diagnostics, Inc. PP&E (Net) History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$2.3M
FY2025
5-year range
$1.9M / $3.0M
FY2021-FY2025
Trend
-17.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $3M to $2M over the past 2 years.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of +19.1%.
Declined from $3M to $2M over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -3.6%
- 5-Year CAGR
- +19.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +19.1%, indicating consistent growth.
- In FY2025, pp&e (net) decreased 17.7% year-over-year.
- Peak pp&e (net) was recorded in FY2023.
- Lowest pp&e (net) in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.3M | -17.7% |
| FY2024 | $2.8M | -9.0% |
| FY2023 | $3.0M | +19.5% |
| FY2022 | $2.5M | +31.4% |
| FY2021 | $1.9M | +103.6% |
| FY2020 | $949.6K | +382.5% |
| FY2019 | $196.8K | +26.1% |
| FY2018 | $156.1K | -5.7% |
| FY2017 | $165.6K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026